GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $350,000 | -23.6% | 8,031 | -22.7% | 0.03% | -19.5% |
| Q4 2021 | $458,000 | -6.7% | 10,390 | -19.1% | 0.04% | -16.3% |
| Q3 2021 | $491,000 | +25.3% | 12,840 | +30.5% | 0.05% | +22.5% |
| Q2 2021 | $392,000 | +11.7% | 9,840 | 0.0% | 0.04% | +5.3% |
| Q1 2021 | $351,000 | -3.0% | 9,840 | 0.0% | 0.04% | -9.5% |
| Q4 2020 | $362,000 | -2.2% | 9,840 | +0.2% | 0.04% | -16.0% |
| Q3 2020 | $370,000 | -7.7% | 9,823 | 0.0% | 0.05% | -13.8% |
| Q2 2020 | $401,000 | +2.6% | 9,823 | -4.8% | 0.06% | -12.1% |
| Q1 2020 | $391,000 | -21.3% | 10,323 | -2.5% | 0.07% | +8.2% |
| Q4 2019 | $497,000 | +6.0% | 10,586 | -3.6% | 0.06% | -1.6% |
| Q3 2019 | $469,000 | -0.6% | 10,986 | -6.9% | 0.06% | -1.6% |
| Q2 2019 | $472,000 | -5.0% | 11,798 | -0.8% | 0.06% | -10.0% |
| Q1 2019 | $497,000 | -9.3% | 11,898 | -17.0% | 0.07% | -19.5% |
| Q4 2018 | $548,000 | -11.6% | 14,335 | -7.1% | 0.09% | +6.1% |
| Q3 2018 | $620,000 | +0.3% | 15,427 | +0.7% | 0.08% | +74.5% |
| Q2 2018 | $618,000 | +1.3% | 15,327 | -1.9% | 0.05% | -47.8% |
| Q1 2018 | $610,000 | +22.7% | 15,627 | +11.4% | 0.09% | +26.8% |
| Q4 2017 | $497,000 | -58.4% | 14,027 | -52.3% | 0.07% | -59.0% |
| Q3 2017 | $1,194,000 | -7.4% | 29,425 | -1.7% | 0.17% | -11.7% |
| Q2 2017 | $1,290,000 | +5.0% | 29,925 | +2.7% | 0.20% | -0.5% |
| Q1 2017 | $1,229,000 | +6.2% | 29,138 | -3.0% | 0.20% | 0.0% |
| Q4 2016 | $1,157,000 | -11.4% | 30,048 | -0.8% | 0.20% | -12.8% |
| Q3 2016 | $1,306,000 | +5.1% | 30,288 | +5.7% | 0.23% | -1.3% |
| Q2 2016 | $1,243,000 | +5.1% | 28,668 | -1.7% | 0.23% | -5.8% |
| Q1 2016 | $1,183,000 | +17.4% | 29,178 | +16.8% | 0.24% | +14.6% |
| Q4 2015 | $1,008,000 | -17.7% | 24,990 | -15.1% | 0.21% | -18.8% |
| Q2 2015 | $1,225,000 | -15.2% | 29,421 | -6.0% | 0.26% | -14.7% |
| Q1 2015 | $1,445,000 | -46.8% | 31,297 | -50.8% | 0.31% | +4.8% |
| Q4 2014 | $2,718,000 | +24.8% | 63,624 | +34.3% | 0.29% | -38.3% |
| Q3 2014 | $2,178,000 | -20.8% | 47,381 | -7.8% | 0.47% | -20.8% |
| Q2 2014 | $2,749,000 | +0.3% | 51,406 | +0.3% | 0.60% | -10.1% |
| Q1 2014 | $2,740,000 | +6.6% | 51,273 | +6.5% | 0.66% | +0.2% |
| Q4 2013 | $2,570,000 | +1.1% | 48,149 | -5.0% | 0.66% | -7.9% |
| Q3 2013 | $2,543,000 | +161.9% | 50,693 | +160.8% | 0.72% | +150.9% |
| Q2 2013 | $971,000 | – | 19,434 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |